Venture Partner at Catalio Capital Management
View Live Interactive Profile →Catalio Capital Management lists Sangeeta N. Bhatia as a Venture Partner. The firm's profile page gives the current affiliation as Director, Marble Center for Cancer Nanomedicine at Massachusetts Institute of Technology. Her stated honours include the Lemelson-MIT Prize (2014), the Heinz Medal (2015), the Othmer Gold Medal (2019) and election to the National Academies of Sciences (2017), Medicine (2019) and Engineering (2015). Catalio's page lists her as a co-founder of Hepregen (now BioVT), Glympse Bio, Satellite Bio and Impilio Therapeutics, and states that she serves on the boards of Vertex Pharmaceuticals and Brown University; those seats were not confirmed against issuer filings and are therefore not recorded as board seats.